Lei Hu1,2,#, Meng Chen2,3,#, Haiming Dai2,3,4, Hongzhi Wang2,3,4,*, Wulin Yang2,3,4,*
Oncologie, Vol.24, No.4, pp. 803-822, 2022, DOI:10.32604/oncologie.2022.026419
- 31 December 2022
Abstract Background and Aim: Hundreds of consistently altered metabolic genes have been identified in breast cancer
(BC), but their prognostic value remains to be explored. Therefore, we aimed to build a prediction model based
on metabolism-related genes (MRGs) to guide BC prognosis. Methods: Current work focuses on constructing a
novel MRGs signature to predict the prognosis of BC patients using MRGs derived from the Virtual Metabolic
Human (VMH) database, and expression profiles and clinicopathological data from The Cancer Genome Atlas
(TCGA) and Gene Expression Omnibus (GEO) databases. Results: The 3-MRGs-signature constructed by SERPINA1, QPRT and PXDNL was found… More >